Prolonged role of itraconazole in the treatment of allergic bronchopulmonary aspergillosis
Joint Authors
Source
Journal of Case Reports in Medicine
Issue
Vol. 2, Issue 2013 (31 Dec. 2013), pp.1-3, 3 p.
Publisher
Publication Date
2013-12-31
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Oral corticosteroids are first-line therapy for allergic bronchopulmonary aspergillosis (ABPA), however, itraconazole has been recognized as an adjunctive treatment.
This paper describes the prolonged use of itraconazole in an asthmatic patient with a diagnosis of ABPA.
This case report features a patient who showed benefit with a longer duration of itraconazole therapy without demonstrating adverse events related to treatment over nearly eight years.
Prolonged treatment with itraconazole may serve as a corticosteroid sparing option for ABPA patients.
American Psychological Association (APA)
Nguyen, Marie& Cohn, John R.. 2013. Prolonged role of itraconazole in the treatment of allergic bronchopulmonary aspergillosis. Journal of Case Reports in Medicine،Vol. 2, no. 2013, pp.1-3.
https://search.emarefa.net/detail/BIM-685716
Modern Language Association (MLA)
Nguyen, Marie& Cohn, John R.. Prolonged role of itraconazole in the treatment of allergic bronchopulmonary aspergillosis. Journal of Case Reports in Medicine Vol. 2 (2013), pp.1-3.
https://search.emarefa.net/detail/BIM-685716
American Medical Association (AMA)
Nguyen, Marie& Cohn, John R.. Prolonged role of itraconazole in the treatment of allergic bronchopulmonary aspergillosis. Journal of Case Reports in Medicine. 2013. Vol. 2, no. 2013, pp.1-3.
https://search.emarefa.net/detail/BIM-685716
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 2-3
Record ID
BIM-685716